Hostname: page-component-76fb5796d-2lccl Total loading time: 0 Render date: 2024-04-29T06:49:30.456Z Has data issue: false hasContentIssue false
  • English
  • Français

Antibiotic Resistance Is Selected Primarily in Our Patients

Published online by Cambridge University Press:  02 January 2015

Jean-Claude Pechere
Jean-Claude Pechere*
Affiliation:
Department of Genetics and Microbiology, University of Geneva Medical School, Geneva, Switzerland
*
9 Avenue de Champel, 1211 Geneva, Switzerland
Get access Rights & Permissions [Opens in a new window]

Abstract

The potential for bacterial resistance probably existed prior to the arrival of humans on earth and bacterial populations isolated before the antibiotic era surely contained antibiotic-resistant organisms. Antibiotic resistance has undergone an explosive development following the introduction of antibiotics in medical practice and in agriculture, and there is no doubt that the higher prevalence of bacterial resistance is closely related to human activities. Strict infection control policies limit the risk of patient-to-patient transmission of resistant as well as susceptible bacteria.

Type
From the Third International Conference on the Prevention of Infection
Information
Infection Control & Hospital Epidemiology , Volume 15 , Issue 7 , July 1994 , pp. 472 - 477
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1994

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Cohen, MTEpidemiology of drug resistance: implications for a post-antimicrobial era. Science 1992;257:1050–1055.Google Scholar
2.Marchou, B, Michéa-Hamzehpour, M, Lucain, C, Péchère, JC. Resistance after p-lactam therapy in a murine model of E cloacae infection. J Infect Dis 1987;156:369–373.Google Scholar
3.Péchère, JC, Marchou, B, Michéa-Hamzehpour, M, Auckenthaler, REmergence of resistance after therapy with antibiotics used alone or combined in murine model. J Antimicrob Chemother 1986;17(suppl A):11–18.Google Scholar
4.Michéa-Hamzehpour, M, Auckenthaler, R, Regamey, P, Péchère, JC. Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis. J Antimicrob Chemother 1987;31:1803–1808.Google Scholar
5.Michéa-Hamzehpour, M, Lucain, C, Péhère, JC. Resistance to pefloxacin in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1991;35:512–518.Google Scholar
6.Lucain, C, Regamey, P, Bellido, F, Péhère, JC. Resistance emerging after pefloxacin therapy of experimental Enterobacter cloacae peritonitis. Antimicrob Agents Chemother 1989;33:937–943.Google Scholar
7.Dalhoff, A. Quinolone resistance in Pseudomonas aeruginosa and Staphylococcus aureus. Development during therapy and clinical significance. Infection 1994;(suppl 2):51–69.Google Scholar
8.Péchère, JC. Emergence of antibiotic resistance during therapy in an animal model. Current Topics Infect Dis Microbiol 1990;3:27–30.Google Scholar
9.Michéa-Hamzehpour, M, Péchère, JC, Marchou, B, Auckenthaler, R. Combination therapy: a way to limit emergence of resistance? Am J Med 1986;80(suppl 6B):138–142.Google Scholar
10.Johnson, DE, Thompson, B, Calia, FM. Comparative activities of piperacillin, ceftazidime, and amikacin alone and in all possible combinations, against experimental Pseudomonas aeruginosa infections in neutropenic rats. Antimicrob Agents Chemother 1985;27:735–739.Google Scholar
11.Bayer, AS, Norman, D, Kim, KS. Efficacy of amikacin and ceftazidime in experimental aortic valve endocarditis due to Pseudomonas aeruginosa. Antimicrob Agents Chemother 1985;28:781–785.Google Scholar
12.Milatovic, D. Braveny, I. Development of resistance during antibiotic therapy. Eur J Clin Microbial 1987;6:234–244.Google Scholar
13.Ogle, JW, Reller, LB, Vasil, ML. Development of resistance in Pseudomonas aeruginosa to imipenem, norfloxacin and ciprofloxacin during therapy: proof provided by typing with a DNA probe. J Infect Dis 1988;157:743–748.Google Scholar
14.Chow, JW, Fine, MJ, Shlaes, DM, et al.Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991;115:585–590.Google Scholar
15.Ling, JM, Hui, YM. Cheng, AF, French, GL. Development of trimethoprim resistance in Salmonella typhi during therapy. Pathology 1992;24:190–193.Google Scholar
16.Bellido, F, Vladoianu, IR, Auckenthaler, R. et al.Permeability and penicillin-binding protein alterations in Salmonella muenchen: stepwise resistance acquired during p-lactam therapy. Antimicrob Agents Chemother 1989;33:113–115.Google Scholar
17.Malfertheiner, P. Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment. Scand J Gastroenterol 1993;196:34–37.Google Scholar
18.Dixon, JMS. Pneumococcus resistant to erythromycin and lincomycin. Lancet 1967;1:573.Google Scholar
19.Follath, F, Costa, E, Thommen, A, Frei, R. Burdeska, A, Meyer, J. Clinical consequences of development of resistance to third-generation cephalosporins. Eur J Clin Microbial 1987;6:446–450.Google Scholar
20.Mouton, JW, Den Hollander, JG, Horrevorts, AM. Emergence of antibiotic resistance amongst Pseudomonas aeruginosa isolates from patients with cystic fibrosis. J Antimicrob Chemother 1993;31:919–926.Google Scholar
21.Michéa-Hamzehpour, M, Kahr, A, Péchère, JC. In vitro stepwise selection of resistance to quinolones β-lactams and amikacin in nosocomial gram-negative bacilli. Infection 1994;21(suppl 2):Sl–S6.Google Scholar
22.Wallrauch-Schwarz, C. Voss, A. Milatovic, D. Braveny, I. Development of resistance to new β-lactams and ciprofloxacin during therapy: a prospective study. Presented at the 33rd International Conference on Antimicrobial Agents and Chemotherapy; October 17-20, 1993; New Orleans, Louisiana. Abstract 627.Google Scholar
23.Shalit, I, Berger, SA, Gorea, A, Frimerman, H. Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolated in a general hospital. Antimicrob Agents Chemother 1989;33:593–594.Google Scholar
24.Hori, S, Ohshita, Y, Hiramatsu, K. Sequential acquisition of norfloxacin and ofloxacin resistance by methicilllin-resistant and -susceptible Staphylococcus aureus. Atrtimicrob Agents Chemother 1993;37:2275–2284.Google Scholar
25.Piddock, JJ, Wijnards, WJA, Rise, R. Quinolone/ureidopenicillin cross resistance. Lancet 1987;1:907–908.Google Scholar
26.Ball, P. Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus clinical significance and therapeutic approaches. J Antimicrob Chemother 1990;26(suppl F):165–170.Google Scholar
27.Nichols, L, Gudmundsson, S, Maki, DG. Experience with cefsulodin therapy for lower respiratory tract infections caused by Pseudomonas aeruginosa in adults without cystic fibrosis or granulocytopenia. Rev Infect Dis 1984;6(suppl 3):711–720.Google Scholar
28.Bloom, BR, Murray, CJL. Tuberculosis: commentary on a reemergent killer. Science 1992;257:1055–1062.Google Scholar
29.Jacobson, KL, Cohen, SH, King, JH, Lippert, WE, Inciardi, JF, Iglesisas, T. The relationship between resistance to extended spectrum cephalosporins and antecedent antibiotic use in type I β-lactamase producing organisms. Presented at the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy; October 17-20, 1993; New Orleans, Louisiana. Abstract 625.Google Scholar
30.Nichols, L, Maki, D. The emergence of resistance to β-lactam antibiotics during treatment of Pseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution? Chemotherapia 1985;4:102–108.Google Scholar
31.Collins, T, Gerding, DN. Aminoglycosides versus β-lactams in gram-negative pneumonia. Sem Respir Infect 1991;6:136–146.Google Scholar
32.Moore, WEC, Holdeman, LV. Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Applied Microbiology 1974;27:961–979.Google Scholar
33.Vollaard, EJ, Clasener, HAL. Colonisation resistance. Antimicrob Agents Chemother 1994;38:409–414.Google Scholar
34.Nord, CE, Edland, C. Ecological effects of antimicrobial agents on the human intestinal microflora. Microbiol Ecol Health Dis 1991;4:193–207.Google Scholar
35.Clasener, HAL, Vollaard, EJ, Van Saene, HKF. Selective decontamination and long-term systemic prophylaxis in leukopenia and in mechanical ventilation. Rev Infect Dis 1987;9:295–338.Google Scholar
36.Vollaard, ES, Clasener, HAL, Janssen, AJHM. Influence of cephradin on microbial colonisation resistance in healthy volunteers. Micvob Ecol Health Dis 1992;5:147–153.Google Scholar
37.Nord, CE, Kager, L, Philipson, A, Stiernstedt, G. Impact of imipenem/cilastin therapy on faecal flora. Eur J Clin Microbiol 1984;3:2475–477.Google Scholar
38.Van Saene, HK, Stoutenbeek, CC, Stoller, JK. Selective decontamination of the digestive tract in the intensive care unit: current status and future prospects. Crit Care Med 1992;20:691–703.Google Scholar
39.Neu, HC. The crisis in antibiotic resistance. Science 1992;257:1064–1073.Google Scholar
40.McGowan, JE JrAntimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983;5:1033–1048.Google Scholar
41.Marton, A, Gulyas, M. Munoz, R, Tomasz, A. Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. J Infect Dis 1991;163:542–548.Google Scholar
42.Ward, J. Antibiotic-resistant Streptococcus pneumoniae: clinical and epidemiological aspects. Rev Infect Dis 1981;3:254–266.Google Scholar
43.Kresken, M, Hafner, D, Mittermayer, H, et al. Prevalence of fluoroquinolone resistance in Europe. Infection. In press.Google Scholar
44.Barry, AL, Jones, R. Bacterial antibiotic resistance before and after clinical application in the United States. Bull NY Acad Med 1994;63:217–230.Google Scholar
45.Gerding, DN, Larson, TA, Hugues, RA, Weiler, M. Shanholtzer, C, Peterson, LR. Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrob Agents Chemother 1991;35:1284–1290.Google Scholar
46.Bulger, RJ, Sherris, JC. Decreased incidence of antibiotic resistance among Staphylococcus aureus: a study in a university hospital over a Syear period. Ann Intern Med 1968;69:1099–1108.Google Scholar